Studies have elucidated that the reduction of CDH1 expression increases the cytotoxic effect of PARPi on triple-negative breast cancer cells with or without BRCA defects by inducing DNA damage, checkpoint activation, cell cycle arrest, and cell apoptosis [34]. The gene discussed is CDH1; the disease is triple-negative breast carcinoma.